No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CHE240719C550000
- 5.08
- -1.19-18.98%
15min DelayClose Jul 11 15:59 ET
5.08High5.08Low
5.08Open6.27Pre Close1 Volume1 Open Interest550.00Strike Price508.00Turnover32.98%IV3.65%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry5.08Extrinsic Value100Contract SizeAmericanOptions Type0.3096Delta0.0134Gamma105.42Leverage Ratio-0.6098Theta0.0355Rho32.63Eff Leverage0.2804Vega
Intraday
- 5D
- Daily
News
BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708
BofA Securities analyst Joanna Gajuk maintains $Chemed(CHE.US)$ with a buy rating, and maintains the target price at $708.According to TipRanks data, the analyst has a success rate of 57.0% and a
Chemed Corp: A Buy Rating With Strong Vitas Fundamentals and Growth in Roto-Rooter Services
Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, following the close of trading on the New York Stock
Should Weakness in Chemed Corporation's (NYSE:CHE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Chemed's (NYSE:CHE) recent performance, when its stock has declined 17% over the past three months. However, the company's fundamentals look pretty decent,
Investing in Chemed (NYSE:CHE) Five Years Ago Would Have Delivered You a 51% Gain
Insider Selling: Director Patrick Grace Sells Shares of Chemed Corp (CHE)
Comments
Insiders' substantial selling of Chemed shares over the past year, especially in the last quarter, could be a red flag for investors. The absence of insider purchases during the same period heightens this concern. Despite high insider ownership, the history of share sales adds uncertainty.
Chemed Insiders Sold US$23m Of Shares Suggesting HesitancyChemed's consistent ability to generate high returns on increased capital employed makes it a potential multi-bagger. Despite the stock being more 'expensive' than before, its strong fundamentals make it worthy of further research.
Despite Chemed's poor recent earnings, the high P/E ratio shows investors foresee future growth. They think chances of an earnings slump is low, supporting share price. This suggests strong future growth potential might be making investors pay a premium for the stock.
The market seems to have a higher opinion of Chemed as compared to five years ago, reflecting increased investor sentiment. Recent shareholder returns suggest positive sentiment around the company, possibly hinting at business momentum.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Align Technology(ALGN.US$ - up 11.5%
2. $Textron(TXT.US$ - up 5.2%
3. $STMicroelectronics(STM.US$ - up 4.1%
4. $Lam Research(LRCX.US$ - up 3.9%
5. $RELX PLC(RELX.US$ - up 3.1%
6. $Royal Caribbean(RCL.US$ - up 3.1%
7. $Micron Technology(MU.US$ - up 3.1%
8. $Western Digital(WDC.US$ - up 2.9...
Gap Ups
1. $Align Technology(ALGN.US$ - up 11.5%
2. $Textron(TXT.US$ - up 5.2%
3. $STMicroelectronics(STM.US$ - up 4.1%
4. $Lam Research(LRCX.US$ - up 3.9%
5. $RELX PLC(RELX.US$ - up 3.1%
6. $Royal Caribbean(RCL.US$ - up 3.1%
7. $Micron Technology(MU.US$ - up 3.1%
8. $Western Digital(WDC.US$ - up 2.9...
+17
19
Read more